The DOI matches its Crossref record; 270 of the 271 references it cites were found in a registry or an index.
Mechanisms of normal and tumor-derived angiogenesis
Abstract
Often those diseases most evasive to therapeutic intervention usurp the human body's own cellular machinery or deregulate normal physiological processes for propagation. Tumor-induced angiogenesis is a pathological condition that results from aberrant deployment of normal angiogenesis, an essential process in which the vascular tree is remodeled by the growth of new capillaries from preexisting vessels. Normal angiogenesis ensures that developing or healing tissues receive an adequate supply of nutrients. Within the confines of a tumor, the availability of nutrients is limited by competition among actively proliferating cells, and diffusion of metabolites is impeded by high interstitial pressure (Jain RK. Cancer Res 47: 3039–3051, 1987). As a result, tumor cells induce the formation of a new blood supply from the preexisting vasculature, and this affords tumor cells the ability to survive and propagate in a hostile environment. Because both normal and tumor-induced neovascularization fulfill the essential role of satisfying the metabolic demands of a tissue, the mechanisms by which cancer cells stimulate pathological neovascularization mimic those utilized by normal cells to foster physiological angiogenesis. This review investigates mechanisms of tumor-induced angiogenesis. The strategies used by cancer cells to develop their own blood supply are discussed in relation to those employed by normal cells during physiological angiogenesis. With an understanding of blood vessel growth in both normal and abnormal settings, we are better suited to design effective therapeutics for cancer.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“This hypoxic stress acts as a potent inducer of angiogenic signaling, upregulating key factors such as vascular endothelial growth factor (VEGF) [51].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [51]
In the citing paper
“As the tumor expands beyond this size, the limited diffusion capacity results in the formation of hypoxic regions, which drive tumor dormancy [50,51].”
From Modeling Tumor Microenvironment Complexity In Vitro: Spheroids as Physiologically Relevant Tumor Models and Strategies for Their Analysis (2025) · cites this paper as [51]
In the citing paper
“Instead of triggering angiogenesis, some tumors co-opt existing vasculature and grow along the vessels [53][54][55][56], until the demand for nutrients and oxygen becomes too large and angiogenesis starts again [53,55].”
From Cancer-on-chip models for metastasis: importance of the tumor microenvironment (2024) · cites this paper as [53]
In the citing paper
“its presence is essential for initiation of the angiogenic program (76,77)”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [76]
In the citing paper
“VEGF-A is the only bona fide endothelial cell growth factor”
From Adipose tissue remodeling and obesity (2011) · cites this paper as [76]
Citations
Cites
Angiogenesis in cancer and other diseases
Carmeliet, P., & Jain, R. K. (2000) · Nature · doi:10.1038/35025220 · Cited by 9,070
Angiogenesis in cancer, vascular, rheumatoid and other disease
Folkman, J. (1995) · Nature Medicine · doi:10.1038/nm0195-27 · Cited by 7,627
Risau, W. (1997) · Nature · doi:10.1038/386671a0 · Cited by 5,727
Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis
Shweiki, D., Itin, A., Soffer, D., & Keshet, E. (1992) · Nature · doi:10.1038/359843a0 · Cited by 4,617
What Is the Evidence That Tumors Are Angiogenesis Dependent?
Folkman, J. (1990) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/82.1.4 · Cited by 4,509
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth
O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R., & Folkman, J. (1997) · Cell · doi:10.1016/s0092-8674(00)81848-6 · Cited by 4,486
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391
Tumor Cells Secrete a Vascular Permeability Factor That Promotes Accumulation of Ascites Fluid
Senger, D. R., Galli, S. J., Dvořàk, A. M., Perruzzi, C. A., Harvey, V. S., & Dvorak, H. F. (1983) · Science · doi:10.1126/science.6823562 · Cited by 3,969
Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice
Shalaby, F., Rossant, J., Yamaguchi, T. P., Gertsenstein, M., Wu, X.-F., Breitman, M. L., & Schuh, A. C. (1995) · Nature · doi:10.1038/376062a0 · Cited by 3,931
Vascular-specific growth factors and blood vessel formation
Yancopoulos, G. D., Davis, S., Gale, N. W., Rudge, J. S., Wiegand, S. J., & Holash, J. (2000) · Nature · doi:10.1038/35025215 · Cited by 3,699
Flagged first, then by citations
1 of the 271 references couldn’t be matched to a known paper.
Research works printed but not linked: 32
- Ambs S, 1999, Cancer Res, 59, 5773
- Borgstrom P, 1996, Cancer Res, 56, 4032
- Clark RA, 1996, Am J Pathol, 148, 1407
- Compagni A, 2000, Cancer Res, 60, 7163
- Deroanne CF, 1997, Cancer Res, 57, 5590
- Dumont DJ, 1992, Oncogene, 7, 1471
- Dvorak HF, 1995, Am J Pathol, 146, 1029
- Esser S, 1998, J Cell Sci, 110, 2065
- Folkman J, 1988, Am J Pathol, 130, 393
- Gately S, 1996, Cancer Res, 56, 4887
- Goto F, 1993, Lab Invest, 69, 508
- Healy AM, 1992, Eur J Cell Biol, 59, 56
- Hughes S, 2000, Invest Ophthalmol Vis Sci, 41, 1217
- Jain RK., 1987, Cancer Res, 47, 3039
- Kitsukawa T, 1995, J Biol Chem, 121, 4309
- Kohn S, 1992, Lab Invest, 67, 596
- Korhonen J, 1994, Oncogene, 9, 395
- Luca M, 1997, Am J Pathol, 151, 1105
- Maglione D, 1993, Oncogene, 8, 925
- Merwin JR, 1991, Am J Pathol, 138, 37
- Millauer B, 1996, Cancer Res, 56, 1615
- Nicosia RF, 1994, Am J Pathol, 145, 1023
- Pajusola K, 1992, Cancer Res, 52, 5738
- Pierce GF, 1992, Am J Pathol, 140, 1375
- Senger DR, 1996, Am J Pathol, 149, 293
- Senger DR, 1986, Cancer Res, 46, 5629
- Takahashi Y, 1995, Cancer Res, 55, 3964
- Tanaka T, 1998, Cancer Res, 58, 3362
- Todaro GJ, 1990, Semin Cancer Biol, 1, 257
- Topp MS, 1995, Cancer Res, 55, 2173
- Vlodavsky I, 2000, Isr Med Assoc J, 2, 37
- Ziche M, 1982, J Natl Cancer Inst, 69, 475
Cited by
Sorted by citations
Items 501–600 of 808
Semiautomatic Quantification of Angiogenesis
Boettcher, M., GLOE, T. R., & de Wit, C. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2008.12.009 · Cited by 10
Kato, H., Ohta, S., Koshida, S., Narita, T., Taga, T., Takeuchi, Y., & Sugita, K. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01401.x · Cited by 10
Dynamic Modeling of the Angiogenic Switch and Its Inhibition by Bevacizumab
Csercsik, D., & Kovács, L. (2019) · Complexity · doi:10.1155/2019/9079104 · Cited by 9
Derakhshani, A., Hesaraki, S., Nezafati, N., & Azami, M. (2021) · Journal of Biomaterials Science Polymer Edition · doi:10.1080/09205063.2021.2008786 · Cited by 9
Intra-tumoral angiogenesis correlates with immune features and prognosis in glioma
Zhang, Q. H., Guo, Y., Zhang, W., Lian, H.-Y., Iranzad, N., Wang, E., Li, Y., Tong, H.-C., Li, L.-Y., Dong, L.-Y., et al. (2022) · Aging · doi:10.18632/aging.204079 · Cited by 9
Phosphatase inhibitors with anti‐angiogenic effect in vitro
Sylvest, L., BENDIKSEN, C. D., & Houen, G. (2009) · Apmis · doi:10.1111/j.1600-0463.2009.02561.x · Cited by 10
Ma, Q., Min, K., Wang, T., Chen, B., Wen, Q., Wang, F., Ji, T., & Gao, S. (2015) · Annals of Nuclear Medicine · doi:10.1007/s12149-015-0975-5 · Cited by 9
Combined Ang-2 and VEGF Targeting Therapies in Renal Cell Carcinoma
Molnar, N., & Siemann, D. W. (2013) · Journal of Cancer Therapy · doi:10.4236/jct.2013.49a2001 · Cited by 9
Ribatti, D., & Crivellato, E. (2011) · Springer eBooks · doi:10.1007/978-94-007-1469-4_6 · Cited by 9
Yavari, N., Emamian, F., Yarani, R., Mohammadi‐Motlagh, H. R., Mansouri, K., & Mostafaie, A. (2014) · Pharmaceutical Biology · doi:10.3109/13880209.2014.946057 · Cited by 9
Delta-24-RGD Induces Cytotoxicity of Glioblastoma Spheroids in Three Dimensional PEG Microwells
Avci, N. G., Fan, Y., Dragomir, A., Akay, Y. M., Gomez‐Manzano, C., Fueyo-Margareto, J., & Akay, M. (2015) · IEEE Transactions on NanoBioscience · doi:10.1109/tnb.2015.2499312 · Cited by 9
Vascular Endothelial Growth Factor (VEGF)
Salajegheh, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28140-7_58 · Cited by 9
Kottamasu, P. K., & Herman, I. M. (2018) · Journal of Tissue Engineering · doi:10.1177/2041731418772949 · Cited by 9
Self-citationEllethy, A. T. (2019) · Europe PMC (PubMed Central) · Cited by 9
Modelo de angiogênese inflamatória em córnea de coelho induzida pela cauterização alcalina pontual
Fechine, F. V., Júnior, J. U. F., & de Moraes, M. O. (2005) · Acta Cirúrgica Brasileira · doi:10.1590/s0102-86502005000100010 · Cited by 9
Antiangiogenic therapy and surgical practice
John, A. R., Bramhall, S. R., & Eggo, M. C. (2008) · British journal of surgery · doi:10.1002/bjs.6108 · Cited by 9
Angiogenesis and Endometriosis
Groothuis, P. G. (2011) · Wiley eBooks · doi:10.1002/9781444398519.ch19 · Cited by 10
Tumor-targeting drug delivery regimens based on vascular disrupting agents
Ye, D., Chen, Y., Xu, H., Zheng, M., Liu, Z., & Tang, Z. (2024) · Precision medicine and engineering. · doi:10.1016/j.preme.2024.100003 · Cited by 8
Role of MicroRNA-204 in Regulating the Hallmarks of Breast Cancer: An Update
Bermúdez, M., Martínez-Barajas, M. G., Bueno-Urquiza, L. J., López-Gutiérrez, J., Villegas‐Mercado, C. E., & López‐Camarillo, C. (2024) · Cancers · doi:10.3390/cancers16162814 · Cited by 8
Multi-target and natural product-based multi-drug approach for anti-VEGF resistance in glioblastoma
Soumya, S. J., Arya, K. R., Abhinand, C. S., Sunitha, P., Athira, A. P., Nair, A. S., Oommen, O. V., & Sudhakaran, P. R. (2024) · Exploration of Drug Science · doi:10.37349/eds.2024.00062 · Cited by 8
Interleukin‐24: A Multidimensional Therapeutic for Treatment of Human Diseases
Raguraman, R., Munshi, A., & Ramesh, R. (2025) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.70013 · Cited by 8
Hernández-Aceves, J. A., Cervantes‐Torres, J. B., Torres‐García, D., Zuñiga-Flores, F. J., Patiño-Chávez, O. J., Agudelo, J. A. P., Aguayo-Flores, J. E., Garfias, Y., Montero, L., Romero-Romero, L., et al. (2023) · Cancer Immunology Immunotherapy · doi:10.1007/s00262-023-03538-9 · Cited by 8
The tumor microenvironment as a target for anticancer treatment
Bizzarri, M., Cucina, A., & Proietti, S. (2014) · Oncobiology and Targets · doi:10.4103/2395-4469.145341 · Cited by 8
The Pleiotropic Effects of miRNAs on Tumor Angiogenesis
Yin, R., Guo, L., Zhang, W., & Zheng, J. (2013) · Journal of Cellular Biochemistry · doi:10.1002/jcb.24679 · Cited by 8
Delivery of Antiangiogenic Agents for Cancer Gene Therapy
Dickson, P. V., Nathwani, A. C., & Davidoff, A. M. (2005) · Technology in Cancer Research & Treatment · doi:10.1177/153303460500400403 · Cited by 8
Zhou, S., & Zhang, H. (2020) · Anti-Cancer Agents in Medicinal Chemistry · doi:10.2174/1871520620666200207091653 · Cited by 7
Hassan, Q. N., Queen, N. J., & Cao, L. (2020) · Translational Cancer Research · doi:10.21037/tcr.2020.02.39 · Cited by 7
Chimeric Antigen Receptors for the Tumour Microenvironment
Habib, R., Nagrial, A. M., Micklethwaite, K. P., & Gowrishankar, K. (2020) · Advances in experimental medicine and biology · doi:10.1007/978-3-030-44518-8_8 · Cited by 8
Expression of early angiogenesis indicators in mature versus immature teeth
Caviedes‐Bucheli, J., Lopez‐Moncayo, L. F., Muñoz‐Alvear, H. D., Hernandez-Acosta, F., Pantoja-Mora, M., Rodriguez-Guerrero, A. S., Ordoñez, A. L., Díaz, L. E., Gomez‐Sosa, J. F., & Muñoz, H. R. (2020) · BMC Oral Health · doi:10.1186/s12903-020-01313-1 · Cited by 8
Bioinformatic approaches to the investigation of the atavistic genes implicated in cancer
Louka, A., Takan, I., Pavlopoulou, A., & Georgakilas, A. G. (2021) · Frontiers in Bioscience-Landmark · doi:10.52586/4944 · Cited by 8
Stephen, N. M., Rudresh, D. U., Maradagi, T., Sugawara, T., Hirata, T., & Ponesakki, G. (2023) · MedComm – Oncology · doi:10.1002/mog2.22 · Cited by 10
Zhang, T., Lee, W., Rui, Y., Cheng, T. Y., & Li, G. (2013) · Annals of Oncology · doi:10.1093/annonc/mdt047.9 · Cited by 8
Angiostatin inhibits pancreatic cancer cell proliferation and growth in nude mice
Yang, D.-Z. (2005) · World Journal of Gastroenterology · doi:10.3748/wjg.v11.i32.4992 · Cited by 8
The Cerebral Microvasculature and Responses to Ischemia
del Zoppo, G. D., & Hamann, G. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4160-5478-8.10002-8 · Cited by 9
Targeted delivery of anticancer drugs: new trends in lipid nanocarriers
Oliveira, M. S., Mendes, L. P., & Torchilin, V. P. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46144-3.00018-0 · Cited by 8
β1 Integrins Mediate Tubule Formation Induced by Supernatants Derived from KSHV-Infected Cells
Dyson, O. F., Bryan, B. A., Lambert, P. J., Ford, P. W., & Akula, S. M. (2007) · Intervirology · doi:10.1159/000101995 · Cited by 8
Angiopoietin-1 and Myeloma-Induced Angiogenesis
Giuliani, N., Colla, S., Morandi, F., & Rizzoli, V. (2004) · Leukemia & lymphoma/Leukemia and lymphoma · doi:10.1080/1042-8190400001022 · Cited by 8
Wartenberg, M., Finkensieper, A., Hescheler, J., & Sauer, H. (2006) · Humana Press eBooks · doi:10.1385/1-59745-046-4:313 · Cited by 8
Distinctive Roles of YAP and TAZ in Human Endothelial Progenitor Cells Growth and Functions
Klaihmon, P., Lorthongpanich, C., Kheolamai, P., Luanpitpong, S., & Issaragrisil, S. (2022) · Biomedicines · doi:10.3390/biomedicines10010147 · Cited by 7
Advances in Engineered Biomaterials Targeting Angiogenesis and Cell Proliferation for Cancer Therapy
Yadav, P., Dua, C., & Bajaj, A. (2022) · The Chemical Record · doi:10.1002/tcr.202200152 · Cited by 7
Raźny, U., Wątor, Ł., Polus, A., Kieć‐Wilk, B., Wan, Y. Y., Dyduch, G., Tomaszewska, R., & Dembinska-Kiec, A. (2010) · Pharmacological Reports · doi:10.1016/s1734-1140(10)70370-4 · Cited by 7
Embryonic Vasculogenesis in Nodular Melanomas and Tumour Differentiation
Iyengar, B., & Singh, A. V. (2011) · Pathology & Oncology Research · doi:10.1007/s12253-010-9350-y · Cited by 7
Influence of Tumor Microenvironment on Thermoresponse
Baronzio, G. F., Gramaglia, A., Baronzio, A., & Freitas, I. (2008) · Springer eBooks · doi:10.1007/978-0-387-33441-7_5 · Cited by 7
Özbudak, İ. H., Özbilim, G., Küçükosmanoğlu, İ., Dertsiz, L., & Demircan, A. (2008) · International Journal of Surgical Pathology · doi:10.1177/1066896908323506 · Cited by 7
Lv, W.-W., Qin, S.-N., Chen, C., Zhang, J., Ren, T., Xu, Y., & Zhao, Q.-C. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2013.194 · Cited by 7
Lvova, T. Y., Игоревна, С. О., Furaeva, K. N., Korenkov, D. A., Соколов, Д. И., & Selkov, S. А. (2013) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-013-2092-6 · Cited by 6
Single-cell terahertz spectral characteristics in simulated scattering near-field imaging mode
Wang, J., Yan, S., Li, Z., Zang, Z., Lu, X.-X., & Cui, H. (2020) · OSA Continuum · doi:10.1364/osac.400827 · Cited by 6
Pivotal Role of Peptides in Gastric Carcinoma: Diagnosis and Therapy
Ahmadpour, S., Khodadust, F., Hormati, A., & Eivaziatashbeik, K. (2020) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-020-10104-9 · Cited by 6
Cai, Y., Wu, J., Long, Q., Xu, S., & Li, Z. (2013) · Applied Mathematics and Mechanics · doi:10.1007/s10483-013-1727-x · Cited by 6
Introduction to Angiogenesis in Normal Physiology, Disease and Malignancy
Salajegheh, A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28140-7_1 · Cited by 6
Anti-angiogenic functional food, degenerative disease and cancer
Losso, J. N., & Bansode, R. R. (2004) · Elsevier eBooks · doi:10.1533/9781855739017.4.485 · Cited by 6
Mutants of β2-glycoprotein I: Their features and potent applications
Shen, L., Azmi, N. U., Tan, X. W., Yasuda, S., Wahyuningsih, A. T., Inagaki, J., Kobayashi, K., Ando, E., Sasaki, T., & Matsuura, E. (2018) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2019.01.007 · Cited by 6
The Application of Peptides in Glioma: A Novel Tool for Therapy
Li, L., Chen, J., Ming, Y., Li, B., Fu, R., Duan, D., Li, Z., Ni, R., Wang, X., Zhou, Y., et al. (2021) · Current Pharmaceutical Biotechnology · doi:10.2174/1389201022666210628114042 · Cited by 6
Opto-Acoustic Image Reconstruction and Motion Tracking Using Convex Optimization
Zalev, J., & Kolios, M. C. (2021) · IEEE Transactions on Computational Imaging · doi:10.1109/tci.2021.3110742 · Cited by 6
Embryonic Stem Cells: A Novel Tool for the Study of Antiangiogenesis and Tumor-Induced Angiogenesis
Wartenberg, M., Dönmez, F., Budde, P., & Sauer, H. (2006) · Handbook of experimental pharmacology · doi:10.1007/3-540-31265-x_3 · Cited by 6
Convected element method for simulation of angiogenesis
Pindera, M. Z., Ding, H., & Chen, Z. (2008) · Journal of Mathematical Biology · doi:10.1007/s00285-008-0171-5 · Cited by 6
Pathophysiological and Vascular Characteristics of Solid Tumors in Relation to Drug Delivery
Vaupel, P. W. (2011) · doi:10.1002/9783527634057.ch2 · Cited by 6
A TRP to Pathological Angiogenesis and Vascular Normalization
Katari, V., Dalal, K. K., Adapala, R. K., Guarino, B. D., Kondapalli, N. B., Paruchuri, S. M., & Thodeti, C. K. (2024) · Comprehensive physiology · doi:10.1002/cphy.c230014 · Cited by 11
"Iogurte" de soja como coadjuvante no tratamento de câncer de mama.
Kinouchi, F. L. (2006) · Americanae (AECID Library) · Cited by 6
Blades and barriers: Oral vaccines for conquering cancers and warding off infectious diseases
Yang, K., Liu, J., Zhao, Y., Xu, H., Zu, M., Li, B., Shi, X., Reis, R. L., Kundu, S. C., & Xiao, B. (2025) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2025.05.038 · Cited by 5
New Three-Dimensional NLS-bio-feedback Approaches in Site Specific Diagnosis of Cancer
Ebrahimi, M., Nesterova, V. I., & Nesterov, V. I. (2017) · Springer eBooks · doi:10.1007/978-3-319-64550-6_23 · Cited by 5
The role of matrix metalloproteinases in cancer progression, in particular metastasis
Alsayad, F. A. S. (2018) · Archives of Medical Science - Civilization Diseases · doi:10.5114/amscd.2018.81070 · Cited by 5
Effective blocking of neuropilin-1activity using oligoclonal nanobodies targeting different epitopes
Karami, E., Moghaddam, M. M., Behdani, M., & Kazemi‐Lomedasht, F. (2022) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2022.2111583 · Cited by 5
Fernando, W., MacLean, E., Monro, S. M. A., Coombs, M. R. P., Marcato, P., Rupasinghe, H. P. V., & Hoskin, D. W. (2024) · Biomolecules · doi:10.3390/biom14070769 · Cited by 5
Antiangiogenic Agents in Natural Products for the Treatment of Gynecologic Disorders
Aghamohammadi, A., & Hosseinimehr, S. J. (2014) · Nutrition and Cancer · doi:10.1080/01635581.2014.865136 · Cited by 5
Vascularisation of Skeletal Muscle
Ranjbar, K., & Fayazi, B. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85903 · Cited by 5
Where does Radioimmunotherapy Fit in the Management of Breast Cancer?
Doddamane, I., Butler, R., Jhaveri, A. P., Chung, G. G., & Cheng, D. (2013) · Immunotherapy · doi:10.2217/imt.13.78 · Cited by 5
Bae, J. Y., Koo, G. H., Park, S. C., & Shin, K. O. (2019) · The Asian Journal of Kinesiology · doi:10.15758/ajk.2019.21.2.51 · Cited by 5
Shen, L., Zhu, X., Wang, Y., Zeng, W., Wu, G., Xue, H., & Chen, B. (2007) · Biological Chemistry · doi:10.1515/bc.2008.016 · Cited by 5
Moon, J. I., Kim, J. M., Jung, G. O., Chun, J. M., Choi, G., Park, J. B., Kwon, C. H. D., Kim, S. J., & Joh, J. (2008) · The Korean Journal of Hepatology · doi:10.3350/kjhep.2008.14.2.185 · Cited by 5
Angiogenic switch in Barrett's adenocarcinoma: the role of vascular endothelial growth factor
Islam, A. (2006) · Frontiers in bioscience · doi:10.2741/1973 · Cited by 5
Yun, S., Lee, J., Jung, K. H., Lee, H., Lee, S., Hong, S., & Hong, S. (2013) · International Journal of Oncology · doi:10.3892/ijo.2013.1912 · Cited by 5
Growth Factor Synergy in Angiogenesis
Ljubimov, A. V. (2008) · Springer eBooks · doi:10.1007/978-1-4020-6780-8_16 · Cited by 5
Efficacy and Safety of Aflibercept and Its Role in the Treatment of Metastatic Colorectal Cancer
Salem, M. E., & El-Refai, S. M. (2013) · Rare Cancers and Therapy · doi:10.1007/s40487-013-0002-8 · Cited by 4
Валентинович, К. А., Berezkina, M. E., Gert, T. N., Sinyavin, S. A., Selkov, S. А., & Соколов, Д. И. (2022) · Medical Immunology (Russia) · doi:10.15789/1563-0625-paf-2376 · Cited by 4
Валентинович, К. А., Gert, T. N., Berezkina, M. E., Sinyavin, S. A., Mikhailova, V. A., Markova, K. L., Simbirtsev, A. S., Selkov, S. А., & Соколов, Д. И. (2022) · Journal of Evolutionary Biochemistry and Physiology · doi:10.1134/s0022093022070171 · Cited by 4
Lu, X., Zhao, L., Xue, T., & Zhang, H. (2013) · PubMed · Cited by 4
Multipotent Astrocytic Stem Cells Identified During Angiogenesis In Melanoma
Iyengar, B. (2011) · Cited by 4
Chen, H.-J., Zhang, W., Hu, L., Fan, J., Zhang, L., & Yan, Y. (2020) · Toxicology · doi:10.1016/j.tox.2020.152506 · Cited by 4
Macrophage cytotoxic activity and its role in the tumor pathogenesis
Kovaleva, O. V., Алексеевна, П. П., & Gratchev, A. N. (2022) · Almanac of Clinical Medicine · doi:10.18786/2072-0505-2022-50-008 · Cited by 5
Percutaneous Needle Electrolysis Accelerates Functional Muscle Regeneration in Mice
Valera‐Garrido, F., Margalef, R., Bosque, M., Minaya‐Muñoz, F., & Santafé, M. M. (2022) · Applied Sciences · doi:10.3390/app121910014 · Cited by 4
El-Nabarawy, E. A., El‐Hanafy, G. M., Rashed, L. A., & Yasin, F. S. (2015) · International Journal of Dermatology · doi:10.1111/ijd.13191 · Cited by 4
Y-27632 Impairs Angiogenesis on Extra-Embryonic Vasculature in Post-Gastrulation Chick Embryos
Duess, J. W., Gosemann, J., Gheorghescu, A. K., Puri, P. S., & Thompson, J. (2023) · Toxics · doi:10.3390/toxics11020134 · Cited by 4
The Role of VEGF in the Process of Neovasculogenesis
Sobczyńska-Rak, A. (2012) · InTech eBooks · doi:10.5772/30233 · Cited by 4
Kaneoya, K., Ueda, T., Suito, H., Nanazawa, Y., Tamaru, J., Isobe, K., Naya, Y., Tobe, T., Motoori, K., Yamamoto, S., et al. (2008) · Radiation Medicine · doi:10.1007/s11604-007-0217-4 · Cited by 4
Tumor-associated macrophages in the prospect of development of targeted anticancer
Skivka, L. M., Gorbik, G. V., Федорчук, О. Г., & Позур, В. В. (2009) · Cytology and Genetics · doi:10.3103/s0095452709040094 · Cited by 4
Expression and purification of recombinant human EGFL7 protein
Pićurić, S., Friedrich, M., & Oess, S. (2009) · Protein Expression and Purification · doi:10.1016/j.pep.2009.06.006 · Cited by 4
Functional Issues in Brain Tumor Treatment
Yang, H., & Chopp, M. (2011) · Journal of Neurology & Neurophysiology · doi:10.4172/2155-9562.s5-002 · Cited by 4
Angiogenesis and Antiangiogenesis Therapies: Spear and Shield of Pharmacotherapy
Feng, X. (2016) · Journal of Pharmaceutical Care & Health Systems · doi:10.4172/2376-0419.1000e110 · Cited by 4
Adeyemo, A., Johnson, C. P., Stiene, A., LaSance, K., Qi, Z.-H., Lemen, L., & Schultz, J. E. J. (2020) · Growth Factors · doi:10.1080/08977194.2020.1767612 · Cited by 4
Bordel, R., Laschke, M. W., Menger, M. D., & Vollmar, B. (2005) · Cell and Tissue Research · doi:10.1007/s00441-005-1078-8 · Cited by 4
The Role of Endothelin 3 in Melanoma Progression and Metastasis
Chin, N. L. (2015) · FIU - Digital Commons (Florida International University) · doi:10.25148/etd.fidc000185 · Cited by 3
Angiostatin up-regulation in gastric cancer cell SGC7901 inhibits tumorigenesis in nude mice
Wu, K. (2003) · World Journal of Gastroenterology · doi:10.3748/wjg.v9.i1.59 · Cited by 4
Dehkordi, A. S., Sayahinouri, M., Hosseininia, H. S., Kazempour, A., Araghinia, R. M., Partan, A. S., Sadrabadi, A. E., & Jalili, A. (2023) · Iranian Journal of Blood and Cancer · doi:10.61186/ijbc.15.4.236 · Cited by 3
Zeng, L., Wu, Y., Zhu, L., He, J., Yuan, Y., Wang, X., Tang, K., & Tan, W. (2025) · PLoS ONE · doi:10.1371/journal.pone.0312791 · Cited by 3
Afonso, J., Lara, L. C., & Longatto‐Filho, A. (2012) · InTech eBooks · doi:10.5772/26676 · Cited by 3
Prognostic value of tumour endothelial markers in patients with endometrial cancer
Bersinger, N. A., Schneider, B., Vorburger, S. A., Johann, S., Candinas, D., & Mueller, M. D. (2009) · Oncology Letters · doi:10.3892/ol_00000037 · Cited by 3
Clinical significance of Vascular Endothelial Growth Factor in Egyptian colorectal cancer patients
Afify, M., Samy, N., Hashim, M., & Essam, T. (2008) · Cited by 3
Metadata
- Authors
- Papetti, M., & Herman, I. M.
- Affiliations
- Tufts University (US)
- ORCID
- Herman, Ira M.
- Venue
- American Journal of Physiology-Cell Physiology
- Publisher
- American Physiological Society
- Published
- 2002-05-01
- Volume
- 282
- Issue
- 5
- Pages
- C947-C970
- ISSN
- 0363-6143 (ISSN-L)
- 1522-1563
- OpenAlex
- W2050499474
- Cited by
- 809
- References
- 271
- Citations by year
- 2026: 11 · 2025: 15 · 2024: 19 · 2023: 33 · 2022: 38 · 2021: 32 · 2020: 36 · 2019: 28 · 2018: 20 · 2017: 41 · 2016: 36 · 2015: 45 · 2014: 42 · 2013: 46 · 2012: 41
- FWCI
- 2.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- American Journal of Physiology-Cell Physiology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r01gm055110-04)
- National Eye Institute (R01EY009033, EY09033)
- National Institute of General Medical Sciences (GM55110)
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK034928)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Angiogenesis and VEGF in Cancer
- Health Sciences › Medicine › Oncology › Lymphatic System and Diseases
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- tumor angiogenesis, physiological angiogenesis, tumor blood supply, vascular remodeling, capillary proliferation, interstitial fluid pressure, tumor microenvironment, cancer metabolism
- MeSH terms
- Blood Vessels, Growth Substances, Humans, Models, Cardiovascular, Neoplasms, Neovascularization, Pathologic, Proteins, Receptors, Cell Surface, Neovascularization, Physiologic, Receptor Protein-Tyrosine Kinases, Angiopoietin-2, Receptors, TIE
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review